Cargando…
Maternal-fetal outcomes in patients with immune mediated inflammatory diseases, with consideration of comorbidities: a retrospective cohort study in a large U.S. healthcare system
BACKGROUND: Immune-mediated inflammatory diseases (IMIDs) are likely to complicate maternal health. However, literature data on patients with IMIDs undergoing pregnancy is scarce and often overlooks the impact of comorbidities. METHODS: We investigated 12 selected IMIDs: psoriasis, inflammatory bowe...
Autores principales: | Hwang, Yeon Mi, Wei, Qi, Piekos, Samantha N., Vemuri, Bhargav, Molani, Sevda, Mease, Philip, Hood, Leroy, Hadlock, Jennifer J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441487/ https://www.ncbi.nlm.nih.gov/pubmed/37609126 http://dx.doi.org/10.1101/2023.08.07.23293726 |
Ejemplares similares
-
The impact of maternal SARS-CoV-2 infection and COVID-19 vaccination on maternal-fetal outcomes
por: Piekos, Samantha N., et al.
Publicado: (2022) -
Effect of COVID-19 vaccination and booster on maternal–fetal outcomes: a retrospective cohort study
por: Piekos, Samantha N, et al.
Publicado: (2023) -
The effect of COVID-19 vaccination and booster on maternal-fetal outcomes: a retrospective multicenter cohort study
por: Piekos, Samantha N., et al.
Publicado: (2022) -
Adoption of a National Prophylactic Anticoagulation Guideline for Hospitalized Pregnant Women With COVID-19: Retrospective Cohort Study
por: Hwang, Yeon-Mi, et al.
Publicado: (2023) -
Risk factors for severe COVID-19 outcomes: a study of immune-mediated inflammatory diseases, immunomodulatory medications, and comorbidities in a large US healthcare system
por: Wei, Qi, et al.
Publicado: (2023)